In addition to $SAP (+3,1%) this month, $DNTH (+0%) in my portfolio this month. I came across this U.S. company more by chance, and I see great potential, as the study results so far have been positive and potential future complement inhibitors could give the company a boost.
6D·
🧬 Dianthus Therapeutics: Welcome to the Portfolio
8